Pilot Pen G2 Edge

PBM

NACDS unveils new spot on PBM reform

NACDS unveils new spot on PBM reform

ARLINGTON, Va. – A new television ad from NACDS urges Congress to enact bipartisan pharmacy benefit manager (PBM) reforms that it has advanced in this legislative session. NACDS is warning against squandering the chance to protect Americans’ access to the pharmacies and pharmacists they trust and rely upon. In “Get It Done,” NACDS president and

Private sector overhaul looms in PBM arena

Value-based care is coming to the PBM sector. Blue Shield of California last month launched a program that eschews the entrenched pharmacy benefits management model, replacing it with a consortium of companies — which includes Amazon Pharmacy and Mark Cuban Cost Plus Drug Co. — assembled to change the way prescription drugs are purchased and 

CVS, Walmart reach new PBM network deal

CVS, Walmart reach new PBM network deal

WOONSOCKET, R.I. — CVS Health and Walmart on Friday reached a multi-year agreement in which Walmart will continue participating in the CVS Caremark pharmacy benefit management (PBM) commercial and Managed Medicaid retail pharmacy networks. The companies are not disclosing the financial terms of the new contract. “We are very pleased to have reached a mutually agreeable

CVS Health offers new approach to pricing PBM services

CVS Health offers new approach to pricing PBM services

WOONSOCKET, R.I. — CVS Health is introducing a new approach to pricing pharmacy benefit management services. The new Guaranteed Net Cost pricing model simplifies the financial arrangements underlying PBM contracts and focuses on helping plan sponsors deliver savings through PBM cost management strategies such as formulary, utilization management and performance pharmacy networks. This new model

Pharmacy boosts CVS Health in second quarter

Pharmacy boosts CVS Health in second quarter

WOONSOCKET, R.I. — Rising PBM and specialty pharmacy sales and recently acquired pharmacy businesses lifted revenue at CVS Health Corp. for the second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. CVS Health said Tuesday that for the second quarter ended June 30, sales climbed 17.6% to $43.73 billion from $37.17 billion